The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status
Toxics · 21.04.2023 · 11 (4) · 392
DOI: 10.3390/toxics11040392 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxics, online erschienen am 21.04.2023. Verfasst von Iwona Bialas und 2 weiteren Autor:innen. Beteiligte Einrichtung: CosmetoSAFE Consulting Sp. z o.o., 05-500 Piaseczno, Poland. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
All cosmetics products must be safe under foreseeable conditions of use. Allergenic responses are one of the most frequent adverse reactions noted for cosmetics. Thus, the EU cosmetics legislation requires skin sensitisation assessment for all cosmetics ingredients, including the regulated ones (for which the full toxicological dossier needs to be analysed by the Scientific Committee on Consumer Safety (SCCS)) and those (perceived as less toxic) which are assessed by industrial safety assessors. Regardless of who performs the risk assessment, it should be carried out using scientifically and regulatory body-accepted methods. In the EU, reference methods for chemical toxicity testing are defined in the relevant Annexes (VII–X) of the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Regulation. Recommendations for Skin Sensitization (Skin Sens) testing are provided in Annex VII, and this particular endpoint information is required for all EU-registered chemicals. Historically, in vivo animal and human methods have been used. Both raise ethical doubts, and some of them cause practical problems in the objective analysis of skin sensitising potency. Previous decades of huge effort have resulted in the regulatory acceptance of the alternative Skin Sens IATA (Integrated Approaches to Testing and Assessment) and NGRA (Next Generation Risk Assessment). Regardless of the testing issues, a serious sociological problem are observed within the market: the consumer assumes the presence of strong sensitisers in cosmetics formulations and insufficient risk management tools used by the industry. The present review aims to provide an overview of methods for assessing skin sensitisation. Additionally, it aims to answer the following question: what are the most potent skin sensitisers used in cosmetics? The answer considers the mechanistic background along with the actual regulatory status of ingredients and practical examples of responsible industry solutions in the area of risk management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CosmetoSAFE Consulting Sp. z o.o., 05-500 Piaseczno, Poland.
- The Laboratory of Innovative Research and Analyzes, Institute of Medical Studies, Medical College, Rzeszów University, 35-959 Rzeszow, Poland.
- Department of Regulatory and Forensic Toxicology, Institute of Medical Expertises, 91-205 Łódź, Poland.
ORCID-Profile: Iwona Bialas
Zitieren
APA
Bialas, I., Zelent-Kraciuk, S., & Jurowski, K. (2023). The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status. Toxics, 11(4), 392. https://doi.org/10.3390/toxics11040392
Vancouver
Bialas I, Zelent-Kraciuk S, Jurowski K. The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status. Toxics. 2023;11(4):392. doi:10.3390/toxics11040392
BibTeX
@article{Bialas2023,
author = {Bialas, Iwona and Zelent-Kraciuk, Sandra and Jurowski, Kamil},
title = {The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status},
journal = {Toxics},
year = {2023},
volume = {11},
number = {4},
pages = {392},
doi = {10.3390/toxics11040392}
}
EUVIMED